Bancreek Capital Management LP Lowers Stake in STERIS plc (NYSE:STE)

Bancreek Capital Management LP cut its holdings in STERIS plc (NYSE:STE - Free Report) by 86.4% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 4,350 shares of the medical equipment provider's stock after selling 27,697 shares during the quarter. STERIS accounts for 0.9% of Bancreek Capital Management LP's investment portfolio, making the stock its 19th largest holding. Bancreek Capital Management LP's holdings in STERIS were worth $894,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of STE. Avalon Trust Co bought a new position in shares of STERIS in the 4th quarter worth $30,000. Human Investing LLC bought a new position in shares of STERIS in the fourth quarter valued at approximately $31,000. Anfield Capital Management LLC grew its holdings in STERIS by 100.0% during the fourth quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider's stock worth $37,000 after buying an additional 91 shares in the last quarter. Central Pacific Bank Trust Division grew its stake in shares of STERIS by 65.5% in the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider's stock worth $39,000 after acquiring an additional 76 shares in the last quarter. Finally, Manchester Capital Management LLC boosted its holdings in STERIS by 182.7% during the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider's stock worth $44,000 after purchasing an additional 137 shares during the last quarter. Institutional investors own 94.69% of the company's stock.

STERIS Price Performance

Shares of STE stock traded up $1.25 during trading hours on Wednesday, reaching $223.03. The stock had a trading volume of 578,151 shares, compared to its average volume of 503,667. STERIS plc has a 12 month low of $197.82 and a 12 month high of $248.24. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32. The firm has a market capitalization of $21.91 billion, a PE ratio of 47.35 and a beta of 0.92. The stock's fifty day simple moving average is $221.62 and its 200 day simple moving average is $221.60.

Remove Ads

STERIS (NYSE:STE - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. On average, equities research analysts predict that STERIS plc will post 9.08 EPS for the current year.

STERIS Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, March 21st. Stockholders of record on Thursday, February 20th were given a dividend of $0.57 per share. The ex-dividend date was Thursday, February 20th. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.02%. STERIS's dividend payout ratio (DPR) is presently 48.41%.

Wall Street Analyst Weigh In

STE has been the subject of a number of research analyst reports. Piper Sandler increased their price target on STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a research report on Monday, February 3rd. Stephens reaffirmed an "overweight" rating and set a $240.00 price target on shares of STERIS in a research report on Thursday, February 6th. Finally, JMP Securities reiterated a "market outperform" rating and set a $265.00 target price on shares of STERIS in a research report on Thursday, February 6th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $258.75.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.